We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Avadel Pharmaceuticals PLC | NASDAQ:AVDL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.62 | 18.62 | 19.25 | 0 | 01:00:00 |
Ireland
(State or Other Jurisdiction of Incorporation) |
001-37977
(Commission File Number) |
98-1341933
(I.R.S. Employer
Identification No.) |
||||
Block 10-1
Blanchardstown Corporate Park, Ballycoolin
Dublin 15, Ireland
(Address of Principal Executive Offices) |
Not Applicable
(Zip Code)
|
Item 7.01 |
Regulation FD Disclosure.
|
99.1
|
Presentation materials dated June 9, 2019*
|
|
99.2
|
Press release dated June 4, 2019, issued by Avadel Pharmaceuticals plc*
|
AVADEL PHARMACEUTICALS PLC
|
||
By:
|
/s/ Phillandas T. Thompson
|
|
Phillandas T. Thompson
Senior Vice President, General Counsel and Corporate Secretary |
1 Year Avadel Pharmaceuticals Chart |
1 Month Avadel Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions